Is Node-Positive Prostate Cancer Always a Systemic Disease?

European Urology

Volumn 54, Issue 2, 2008, Pages 243-246

  Briganti, Alberto ^a   Chun, Felix K ^b   Karakiewicz, Pierre I ^c   Rigatti, Patrizio ^a   Montorsi, Francesco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN THERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; EDITORIAL; HUMAN; LYMPH NODE DISSECTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 45849141237     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.05.026     Document Type: Editorial

References (14)

1. Heidehreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 53 (2008) 68-80
2. Heidenreich A., Ohlmann C.H., and Polyakov S. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. Eur Urol 52 (2007) 29-37
3. Briganti A., Chun F.K.-H., Salonia A., et al. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 49 (2006) 1019-1027
4. Briganti A., Karakiewic P.I., Chun F.K.-H., et al. Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection. Eur Urol 51 (2007) 1573-1581
5. Cheng L., Zincke H., Blute M.L., et al. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 91 (2001) 66-73
6. Daneshmand S., Quek M.L., Stein J.P., et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172 (2004) 2252-2255
7. Bader P., Burkhard F.C., Markwalder R., et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?. J Urol 169 (2003) 849-854
8. Boorjian S.A., Thompson R.H., Siddiqui S., et al. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol 178 (2007) 864-871
9. Schumacher M.C., Burkhard F.C., Thalmann G.N., Fleischmann A., and Studer U.E. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol 54 (2008) 344-352
10. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). American Joint Committee on Cancer Staging Manual. 6th ed. (2002), Springer, Philadelphia, PA
11. Briganti A., Karnes J., Da Pozzo L., et al. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 784 consecutive N+ patients. Eur Urol Suppl 7 (2008) 303
12. Messing E.M., Manola J., Yao J., et al. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 7 (2006) 472-479
13. Briganti A., Karnes J.R., Da Pozzo L.F., et al. Development and internal validation of the first nomogram predicting long-term prostate cancer specific survival in patients with node positive prostate cancer treated with radical prostatectomy and pelvic lymph node dissection. J Urol 179 Suppl 4 (2008) 251
14. Palapattu G.S., Allaf M.E., Trock B.J., et al. Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term follow-up. J Urol 172 (2004) 1860-1864